Manchester Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Manchester Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,573	Closed	-$997K	–	1153
2022 Q1	$997K	Hold	8,573	–	–	0.14%	88
2021 Q4	$1.29M	Hold	8,573	–	–	0.17%	77
2021 Q3	$1.02M	Sell	8,573 -1	-0%	-$110	0.14%	97
2021 Q2	$835K	Hold	8,574	–	–	0.12%	119
2021 Q1	$757K	Hold	8,574	–	–	0.11%	133
2020 Q4	$820K	Hold	8,574	–	–	0.13%	114
2020 Q3	$973K	Buy	8,574 +2,071	+32%	+$218K	0.15%	91
2020 Q2	$643K	Hold	6,503	–	–	0.09%	128
2020 Q1	$418K	Hold	6,503	–	–	0.07%	153
2019 Q4	$388K	Hold	6,503	–	–	0.04%	187
2019 Q3	$384K	Hold	6,503	–	–	0.05%	178
2019 Q2	$420K	Hold	6,503	–	–	0.05%	167
2019 Q1	$413K	Buy	+6,503	New	+$342K	0.05%	164
2014 Q4	–	Sell	-1,000	Closed	-$125K	–	1135
2014 Q3	$125K	Hold	1,000	–	–	0.02%	510
2014 Q2	$139K	Hold	1,000	–	–	0.02%	474
2014 Q1	$145K	Hold	1,000	–	–	0.02%	428
2013 Q4	$114K	Buy	+1,000	New	+$229K	0.02%	458

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Manchester Capital Management's TNDM Position: Q2 2022 in Review

Manchester Capital Management sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 8,573 shares — an estimated $997K sold.

Manchester Capital Management first reported a position in TNDM in Q4 2013 and held it in 17 quarters. The position peaked at $1.29M in Q4 2021. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

Manchester Capital Management reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
Manchester Capital Management sold 8,573 Tandem Diabetes Care shares in Q2 2022, an estimated $997K.
Manchester Capital Management first reported a position in Tandem Diabetes Care in Q4 2013 and held it in 17 quarters.
Manchester Capital Management's Tandem Diabetes Care position peaked at $1.29M in Q4 2021.
330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Manchester Capital Management's 13F filing for Q2 2022, filed 10 Aug 2022.